Core Data Elements
Number of Cases
1,705Case Sex
Female (684); Male (1,021)
Case Age At Diagnosis
15 to 19 years (22); 20 to 24 years (152); 25 to 29 years (290); 30 to 34 years (480); 35 to 39 years (761)
Case Race
Not Reported (1,705)
Case Ethnicity
Not Reported (1,705)
Case Disease Diagnosis
Acinar cell carcinoma (1); Acinar cell tumor (3); Adenocarcinoma, diffuse type (14); Adenocarcinoma, intestinal type (2); Adenocarcinoma, NOS (464); Adenoid cystic carcinoma (15); Adnexal carcinoma (2); Adrenal cortical carcinoma (13); Astrocytoma, NOS (84); Atypical carcinoid tumor (1); Basal cell carcinoma, NOS (1); Carcinoid tumor, NOS (2); Carcinoma, NOS (210); Carcinoma, undifferentiated, NOS (4); Carcinosarcoma, NOS (1); Cholangiocarcinoma (21); Chordoma, NOS (8); Clear cell carcinoma (13); Collecting duct carcinoma (1); Duct adenocarcinoma, NOS (11); Ductal carcinoma in situ, NOS (1); Endometrioid adenocarcinoma, NOS (5); Ependymoma, NOS (6); Esthesioneuroblastoma (1); Follicular carcinoma, NOS (3); Gastrointestinal stromal tumor, NOS (8); Germ cell tumor, NOS (24); Glioblastoma (83); Glioma, malignant (25); Granulosa cell tumor, NOS (3); Hepatocellular carcinoma, NOS (24); Infiltrating duct carcinoma, NOS (188); Inflammatory carcinoma (3); Large cell carcinoma, NOS (1); Large cell neuroendocrine carcinoma (8); Lobular carcinoma, NOS (4); Medullary carcinoma, NOS (12); Medulloblastoma, NOS (9); Melanoma, NOS (67); Meningioma, NOS (9); Merkel cell carcinoma (1); Mesothelioma, NOS (18); Metaplastic carcinoma, NOS (2); Mucinous carcinoma (7); Mucoepidermoid carcinoma (4); Myoepithelial carcinoma (3); Neuroblastoma, NOS (4); Neuroendocrine carcinoma, NOS (57); Non-small cell carcinoma (21); Oligodendroglioma, NOS (25); Papillary carcinoma, NOS (10); Papillary renal cell carcinoma (7); Papillary serous adenocarcinoma (1); Paraganglioma, NOS (3); Pheochromocytoma, NOS (1); Pituitary adenoma, NOS (3); Renal cell carcinoma, NOS (15); Sarcomatoid carcinoma (1); Serous carcinoma, NOS (36); Sex cord tumor, NOS (6); Small cell carcinoma, NOS (9); Solid pseudopapillary tumor (1); Spindle cell carcinoma, NOS (1); Squamous cell carcinoma, NOS (65); Thymoma, NOS (6); Urothelial carcinoma, NOS (7); Not Reported (36)
Case Tumor Site
Abdomen, NOS (18); Adrenal gland, NOS (7); Anal canal (1); Appendix (4); Bladder, NOS (7); Bone marrow (1); Bone, NOS (32); Brain, NOS (263); Breast, NOS (191); Cardia, NOS (7); Cervix uteri (20); Colon, NOS (114); Connective, subcutaneous and other soft tissues of thorax (2); Connective, subcutaneous and other soft tissues, NOS (81); Duodenum (3); Esophagus, NOS (17); Extrahepatic bile duct (1); Eye, NOS (1); Fallopian tube (4); Gallbladder (6); Head, face or neck, NOS (19); Heart (5); Kidney, NOS (34); Liver (192); Lung, NOS (117); Lymph node, NOS (139); Major salivary gland, NOS (3); Mediastinum, NOS (17); Mouth, NOS (2); Nasal cavity (8); Other ill-defined sites (15); Ovary (41); Pancreas, NOS (13); Parotid gland (9); Pelvic bones, sacrum, coccyx and associated joints (1); Pelvis, NOS (23); Penis, NOS (1); Peritoneum, NOS (29); Pleura, NOS (22); Rectum, NOS (22); Skin, NOS (29); Small intestine, NOS (15); Specified parts of peritoneum (18); Spleen (1); Stomach, NOS (32); Testis, NOS (4); Thorax, NOS (11); Thymus (2); Thyroid gland (11); Tongue, NOS (10); Trachea (2); Unknown primary site (1); Ureter (2); Uterus, NOS (11); Vagina, NOS (5); Vertebral column (10); Vulva, NOS (2); Not Reported (47)
Number of Samples
36,050Sample Assay Method
Targeted Sequencing (36,050)